FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $1.49, $0.09 better than the analyst estimate of $1.40. Revenue for the quarter came in at $601.5 million versus the consensus estimate of $590.75 million.
James C. Foster, Chairman, President and Chief Executive Officer, said, We believe our strong financial... More

